Thomas KH Leung

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi.

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi.

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada.

Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi.